• IRIS® Registry-Based Studies Evaluate Anti-VEGF Drugs’ Effect on IOP, Visual Acuity Over Time


    Five recent studies using data from the Academy’s IRIS Registry (Intelligent Research in Sight) show exciting potential to provide new insights for disease management based on real-world data.